Total joint replacement (TJR) is very cost-effective surgery for end-stage arthritis. One important goal is to decrease the revision rate, mainly because TJR has been extended to younger patients. Continuous production of ultra-high molecular weight polyethylene (UHMWPE) wear particles induces macrophage infiltration and chronic inflammation, which can lead to periprosthetic osteolysis. Targeting individual pro-inflammatory cytokines directly has not reversed the osteolytic process in clinical trials, owing to compensatory up-regulation of other pro-inflammatory factors. It is hypothesized that targeting the important transcription factor NF-jB could mitigate the inflammatory response to wear particles, potentially diminishing osteolysis. In the current study, NF-jB activity in mouse RAW 264.7 and human THP1 macrophage cell lines, as well as primary mouse and human macrophages, was suppressed via competitive binding with double strand decoy oligodeoxynucleotide (ODN) containing an NF-jB binding element. It was found that macrophage exposure to UHMWPE particles induced multiple proinflammatory cytokine and chemokine expression, including TNF-a, MCP1, MIP1a and others. Importantly, the decoy ODN significantly suppressed the induced cytokine and chemokine expression in both murine and human macrophages, and resulted in suppression of macrophage recruitment. The strategic use of decoy NF-jB ODN, delivered locally, could potentially diminish particle-induced periprosthetic osteolysis.
Introduction
Total joint replacement (TJR) is a cost-effective surgical procedure for end-stage arthritis. As TJR has been extended to younger, more active patients, one important goal is to decrease the surgical revision rate due to wear of the bearing surfaces. The generation of wear particles from the bearing surfaces of implanted biomaterials induces a chronic inflammatory response, which may eventually lead to periprosthetic osteolysis [1, 2] .
Ultra-high molecular weight polyethylene (UHMWPE) still remains the most commonly used biomaterial in the bearing surface of TJR. UHMWPE has a wear rate as high as 0.4 mm year À1 [3] ; UHMWPE particles activate macrophages and secrete proinflammatory cytokines, including TNF-a, IL-1b, MCP1 and others [4] . Although blocking individual cytokines showed promising effects in alleviating wear-particle-induced osteolysis in vitro and in animal studies, a clinical study in humans indicated that blocking TNF-a by neutralizing antibody did not mitigate osteolysis [5] . This could be explained by the compensatory up-regulation of other pro-inflammatory factors. Since wear particles may induce the expression of multiple pro-inflammatory factors, targeting their upstream signaling mechanisms could be an effective therapeutic strategy [6, 7] .
Wear particles can be recognized by toll-like receptors on macrophages, which can activate NF-jB signaling and up-regulate the downstream target gene expression for many chemokines and cytokines [8, 9] . The cytokines are then recognized by cell receptors, which further activate the NF-jB signal intensity as positive feedback regulation. The complexity of the NF-jB-cytokine network makes it difficult to modulate NF-jB activities far upstream. Because of its central role in chronic inflammation and regulation of the function of macrophage-osteoclast lineage cells, direct modulation of NF-jB activity is a logical therapeutic strategy to reduce tissue damage caused by wear particles [10] .
Decoy oligodeoxynucleotide (ODN) is a synthesized duplex DNA, which can suppress transcription factor activity efficiently through competitive binding with endogenous target sequence in the genome [11] . Suppression of NF-jB activity via decoy ODN could be very specific, with a low occurrence of adverse effects, and has been applied to many in vivo or in vitro immune mediated disease models [12] [13] [14] [15] . However, the potential therapeutic effects of NF-jB decoy ODN in wear-particle-induced periprosthetic osteolysis have not been evaluated.
The present study examines the effects of NF-jB decoy ODN in mouse and human macrophages exposed to clinically relevant UHMWPE particles with/without endotoxin in terms of cytokine expression profiles and macrophage recruitment. The results indicate that NF-jB targeting therapy can mitigate the inflammatory response to wear particles, potentially diminishing osteolysis.
Materials and methods

Reagents
Lipopolysaccharide (LPS) was purchased from Sigma (SigmaAldrich, St. Louis, MO). The cationic polymer (C32-122) was generated and used for transfection as previously described [16] . Lipofectamine 2000 was purchased from Invitrogen (Life Technologies, Pleasanton, CA). Lipidoid was generated as previously described [17] . The transfection protocols for Lipofectamine 2000 and Lipidoid were followed according to the instructional manual.
RAW 264.7 and THP1 cell culture
The mouse macrophage cell line RAW 264.7 cells (Cat. TIB-71, ATCC, Manassas, VA) were grown in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine serum (FBS) and an antibiotic/antimycotic solution (100 units of penicillin, 100 lg of streptomycin and 0.25 lg of Amphotericin B per ml; Hyclone, Thermo Scientific). Cells from the human macrophage cell line THP1 (ATCC, Manassas, VA) were grown in RPMI-1640 medium with 10% heat inactivated FBS, 50 nM 2-mercaptoethanol, and the antibiotic/antimycotic solution. THP1 cells were differentiated by plating at a density of 1.5 Â 10 5 cm
À2
, and treated with 50 nM phorbol-12-myristate-13-acetate (PMA; Sigma Aldrich, St. Louis, MO) for 3 days.
Generation of NF-jB luciferase reporter clone in RAW 264.7
The reporter plasmid pGL4.32[luc2/NF-jB-RE/Hygro] Vector was purchased from Promega (Madison, WI). The plasmid was transfected into RAW 264.7 cells with jetPEI Ò -Macrophage (Polyplus Transfection, France), and grown in culture medium containing 150 ng ml À1 hygromycin (Life Technologies, Pleasanton, CA). The luciferase activity was measured by mixing the samples with D-luciferin and read by a Luminometer (Turner Biosystem, Sunnyvale, CA) or IVIS-200 (Perkin Elmer, Santa Clara, CA).
Isolation of mouse bone marrow derived macrophage
Bone marrow was collected from the femora of C57BL6/J male mice 10-12 weeks of age (Jackson Laboratory). The animal protocol was approved by the institutional ethics committee. Institutional guidelines for the care and use of laboratory animals were observed in all aspects of this project. The mice were killed with carbon dioxide (CO 2 ) gas, and sterilized by 70% ethanol before harvesting. The femora were surgically removed while maintaining a sterile technique. Using a syringe and 25-gauge needle, the bone marrow was flushed by injecting 4 ml of culture medium (RPMI1640 medium supplemented with 10% heat inactivated FBS, and the antibiotic/antimycotic solution) through the marrow cavity into a 150 cm 2 dish containing culture medium. The cells were carefully suspended and passed through a 70 lm strainer, spun down, washed three times with culture medium, re-suspended in the culture medium containing 30% of L929 cells conditioned medium and 10 ng ml À1 mouse macrophage colony stimulation factor (M-CSF) and re-plated in T-175 culture flasks at a concentration of 4 Â 10 7 cells per flask. Cells were allowed to expand for 5-7 days, with a medium change at the second day to remove non-adherent cells. The cells were analyzed using surface marker expression (F4/80 and CD11b) after day 7.
Decoy ODN
The NF-jB decoy sequences used are . The synthetic ODNs were a kind gift from Dr. Egashira of Kyushu University, Japan. The ODN were washed with 70% ethanol, dried and dissolved in sterile Tris-EDTA (10 mM Tris, 1 mM EDTA), and the supernatant was purified over a NAP 10 column. For the treatment, macrophages were treated with 0.5 lM ODN for 16 h, and then placed into plates coated with or without UHMWPE. The decoy ODN or scrambled ODN treatment were continually administered during the experiments.
UHMWPE
Conventional UHMWPE particles were a gift from Dr. Timothy Wright (Hospital for Special Surgery, New York) and obtained from knee joint simulator tests and isolated according to an established protocol [18] . Frozen aliquots of the particles containing serum were lyophilized for 4-7 days. The dried material was digested in 5 M sodium hydroxide at 60°C for 1 h, and ultrasonicated for 10 min. The digested particle suspension was centrifuged through a 5% sucrose gradient at 40 k rpm at 10°C for 3 h. The collected particles at the surface of the sucrose solution were incubated at 80°C for 1 h and centrifuged again through an isopropanol gradient (0.96 and 0.90 g cm
À3
) at 40 k rpm at 10°C for 1 h. The purified particles at the interface between the two layers of isopropanol were harvested, and the isopropanol was evaporated from the particle mixture then lyophilized until dry. Particles were then re-suspended in 95% ethanol, which was evaporated completely. The particles tested negative for endotoxin by means of a Limulus Amebocyte Lysate Kit (BioWhittaker, Walkersville, MD). The mean diameter of the particles was 1.0 ± 0.1 lm (mean ± SE, averaged from 125 scanned particles) measured by electron microscopy. The measurement was done by Dr. Lydia-Marie Joubert in the Cell Science Image Facility at Stanford University.
RNA extraction and quantitative polymerase chain reaction
Cellular RNA were extracted using an RNeasy RNA purification kit (Qiagen, Valencia, CA). RNA were reverse transcribed into complementary DNA (cDNA) using a high-capacity cDNA archive kit (Applied Biosystems, Foster City, CA). Probes for 18s rRNA, TNF-a, IL-1b, IL-6 and MCP1 were purchased from Applied Biosystems. Reverse-transcriptase polymerase chain reaction (PCR) was performed in an ABI 7900HT Sequencing Detection System (Applied Biosystems), using the 18s rRNA as the internal control. The ÀDDCt relative quantitation method was used to evaluate the gene expression level.
Multiplex panel cytokine array
The Luminex assay was performed using mouse or human multiplex panel cytokine arrays (Life Technologies, Pleasanton, CA). The instructional manual was followed carefully. Plates were read by Luminex 100, and the results were analyzed by xPONENT Ò software.
Migration assay
Chemotaxis assays were modified slightly from the previous method [19] 
Statistical analysis
One-way ANOVA with Tukey's post-hoc test was conducted using Prism 5 (GraphPad Software, San Diego, CA). Data were reported as mean ± standard error of the mean. The threshold of significance was chosen as p < 0.05.
Results
3.
1. Naked NF-jB decoy ODN-inhibited LPS-induced TNF-a production and UHMWPE-induced NF-jB activation using the mouse RAW 264.7 macrophage cell line RAW 264.7 cells were used to evaluate the delivery efficiency of decoy ODN. Compared with scrambled ODN, direct treatment of 0.5 lM naked NF-jB decoy ODN was sufficient to inhibit 50% of TNF-a production induced by 1 lg ml À1 LPS. A combination of the ODN with a transfection reagent such as cationic polymer [16] or Lipofectamine 2000 was unable to inhibit TNF-a production, while ODN with Lipidoid showed inhibition similar to naked ODN (Fig. 1a) . In addition, cell viability testing of RAW 264.7 showed that Lipidoid decreased the percentage of viable cells by 69.9% (Fig. 1b) . The presence of decoy ODN decreased viable cells either with or without Lipidoid, which suggested that the ODN may suppress the survival and proliferation signals in RAW 264.7 cells. These results suggested that naked ODN is the most efficient delivery strategy for RAW 264.7 cells and has the lowest toxic effect.
The Luciferase reporter plasmid driven by the NF-jB response element was transfected into RAW 264.7 cells to generate a stable cell line (Fig. 1c, upper panel) . The luciferase expression level increased 6-fold in response to NF-jB activation by 1 lg ml À1 LPS treatment (Fig. 1c, lower panel) . The NF-jB activity was increased by 50% in response to UHMWPE, whereas the decoy ODN decreased the particle-induced activation compared with scrambled ODN (Fig. 1d) Together, the results confirmed that the particles could induce NF-jB activation in macrophages, which can be mitigated by decoy ODN.
Decoy ODN-inhibited UHMWPE and LPS-induced cytokine production in murine bone marrow-derived primary macrophages
Murine bone marrow-derived macrophages were isolated and characterized for their cell surface marker expression (Fig. 2a) . Cytokine expression profiles in macrophages including MCP1, TNF-a, IL-1b and IL-6 were first analyzed by quantitative PCR for their significant roles in wear-particle-induced periprosthetic osteolysis [20] [21] [22] . Macrophages exposed to UHMWPE particles induced TNF-a (3.8-fold, peak at 24 h), IL-1b (67.9-fold, peak at 48 h), but not IL-6 or MCP1 expression. Combined exposure of macrophage with UHMWPE plus LPS induced TNF-a (7.3-fold, peak at 12 h), MCP1 (3.5-fold, peak at 48 h), IL-1b (6489-fold, peak at 48 h) and IL-6 (607-fold, peak at 24 h) expression, respectively ( Fig. 2b-e) . Alternatively, decoy ODN significantly inhibited cytokine expression compared with scrambled ODN or the no ODN control group.
Cytokine production in the supernatants was analyzed using the mouse 20-plex panel array. Consistent with the quantitative PCR results, production of TNF-a and IL-1b, but not MCP1 and IL-6, was increased by exposure of macrophages to particles (Fig. 4a, b) . In addition, chemokine production including MIP1a and CXCL1 was also increased by particle exposure (see summary in Table 1 and Supplementary Table 1 ). The chemokines (MCP1, MIP1a, CXCL1) and pro-inflammatory cytokines (TNF-a, IL-1b, IL-6) in the array panels were all inhibited by the decoy ODN (see summary in Table 2 and Supplementary Table 2 ).
Decoy ODN-inhibited UHMWPE and LPS-induced cytokine production in human THP1 macrophages
Human THP1 macrophage exposed to UHMWPE particles induced TNF-a (8.4-fold, peak at 24 h), MCP1 (5.4-fold, peak at 48 h), IL-1b (2-fold, peak at 6 h) and IL-6 (10.2-fold, peak at 24 h) expression at the mRNA level. Macrophages exposed to the combination of UHMWPE particles plus LPS induced TNF-a (11.7-fold, peak at 48 h), MCP1 (863-fold, peak at 24 h), IL-1b (18.9-fold, peak at 6 h) and IL-6 (271-fold, peak at 24 h), respectively (Fig. 3) . Decoy ODN significantly inhibited cytokine expression compared with scrambled ODN or the no ODN control group. Cytokine production in the supernatant was also analyzed using the human 25-plex panel array. Compared with the quantitative PCR results, production of MCP1 and IL-6, but not TNF-a and IL-1b, were increased by macrophage exposure to particles (Fig. 4c, d and Table 1 ). In addition, chemokine production including MIP1a, MIP1b and IL-8 was also increased by particle exposure. Notably, production of RANTES was also significantly suppressed by particle exposure ( Table 1) . The chemokines MCP1, MIP1a, MIP1b, RANTES and IL-8 and the pro-inflammatory cytokines (TNF-a, IL-1b, IL-6 and IL-12) were all inhibited by the decoy ODN (Table 2) .
3.4.
Decoy ODN suppressed THP1 cell migration to the conditioned media from THP1 macrophage exposure to UHMWPE and LPS Using the THP1 cell migration assay, conditioned media from THP1 cells treated with decoy ODN induced less THP1 cell migration at 24 h and 48 h exposure (Fig. 5a and b, respectively) ; however, cell migration studies showed no significant differences at 6 h and 12 h exposure times (data not shown). Consistent with MCP1 production levels (Fig. 4c) , the migrated cell numbers were not affected by decoy ODN treatment in the group of THP1 cells exposed to UHMWPE and LPS for 48 h. The migrated cell number in the particle-treated group increased to 2.6-fold compared with the untreated cell samples (Fig. 5b) , suggesting that cells exposed to UHMWPE induced more macrophage infiltration.
Discussion
The current findings show that targeting the NF-jB pathway could suppress pro-inflammatory cytokine expression induced by UHMWPE wear particles and endotoxin in macrophages. Suppression of the inflammatory response to wear debris in TJR patients using this novel strategy could potentially mitigate particleinduced inflammation in the early high wear ''bedding in'' stage during the first several months after joint replacement, thus producing a more robust interface per primum. Furthermore, if this strategy is implemented at a later time in the early stages of periprosthetic osteolysis, bone loss could be reduced while the wear process continues. It is recognized that the current study reports the results of in vitro experiments, in contrast to the long-term process of particle-induced periprosthetic osteolysis in humans. The present authors plan to extend these encouraging in vitro studies to evaluate the potential of decoy ODN treatment in longer-term experiments using their in vivo murine continuous femoral particle infusion model [23] .
Decoy ODN mediated suppression of NF-jB activity inhibited the production of multiple cytokine and chemokines in primary mouse macrophages and human THP1 cells. This strategy could potentially block wear-particle-mediated osteolysis by several mechanisms. First, decoy NF-jB ODN inhibited the production of pro-inflammatory cytokines including TNF-a and IL-1b, which could mitigate particle-induced tissue damage. Second, inhibition of macrophage attracting chemokines could further reduce the infiltration of circulating macrophages to the inflammatory site. Third, RANK/RANKL mediated osteoclastogenesis is also regulated by the NF-jB pathway and is critical for the osteolytic process. However, the overall biological effects of decoy ODN on the regulation of RANK/RANKL remain to be clarified in vivo, since their expression is more dominant in other cell types [24] .
The direct effects of NF-jB signaling on bone is complicated by the complexity of cell types involved in this specialized tissue micro-environment. NF-jB activation can induce Type I collagen Quantitative PCR analysis was performed using the TaqMan system as described in the Section 2. ⁄ p < 0.05, ⁄⁄ p < 0.01, ⁄⁄⁄ p < 0.005.
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⁄ p < 0.05, ⁄⁄ p < 0.01, ⁄⁄⁄ p < 0.005. System. The migrated cell number was quantified by detecting the double strand DNA concentration using pico-green detection dye. ⁄ p < 0.05, ⁄⁄ p < 0.01.
T.-h. Lin et al. / Acta Biomaterialia xxx (2014) xxx-xxxexpression in osteoprogenitor cells [25] , which can induce bone formation [26] . NF-jB signaling can also modulate inflammation via the secretion of anti-inflammatory cytokines such as IL-10 by mesenchymal stem cells [27, 28] . However, NF-jB can suppress osteogenic differentiation via suppression of b-catenin signaling [29] [30] [31] , or can enhance bone formation via up-regulation of the transcriptional co-activator TAZ [32] . Therefore, the overall effects of NF-jB signaling on osteogenesis remain to be clarified in vivo. Importantly, the neutrophil-attracting chemokines, including IL-8 and CXCL1, were both induced by the exposure to UHMWPE particles. Previous studies have reported that titanium particles trigger neutrophil recruitment in an IL-1a/b-dependent manner [33] . In addition, when neutrophils were exposed to UHMWPE particles, there was a significant correlation between the bactericidal activity of neutrophils and the number and size of the particles [34] . It is likely that the generation of UHMWPE wear particles could recruit neutrophils with impaired bactericidal function, which may further enhance the pro-inflammatory response and inhibit the normal clearance of bacteria.
Previous studies using titanium wear particles and differentiated THP-1 cells have shown variable results [35, 36] , which may be due to the type and dose of particles and cell differentiation strategy. Current studies using PMA-stimulated THP-1 cells that were exposed to UHMWPE particles moderately increased TNF-a expression, which is consistent with a previous study with a similar dose ($1 Â 10 9 particles ml À1 ) of polyethylene particles [36] . Despite the specificity and biological safety, the clinical application of decoy ODN may be limited because of its short half-life. Nevertheless, chemical modifications such as using a phosphothioate bond to replace the phosphodiester bond with sulfur have been shown to be more resistant to DNAase and more stable in serum [11] . In addition, the decoy ODN could be delivered locally by coating it on the implanted biomaterials. Recent studies reported that the surface of implanted devices can be coated with proteins, small molecules or other potentially therapeutic compounds [37, 38] . This novel strategy could affect long-term release in an anatomically localized region, and reduce concerns of potential systemic toxicity. Previous reports showed that NF-jB decoy ODN can be coated on nanoparticles for local delivery [39] , or directly coated onto a catheter for implantation in cardiovascular diseases [40] . In this manner, the application of decoy ODN technology coated on the biomaterials used in TJR may have great potential to mitigate wear-particle-induced osteolysis.
Interestingly, the present data also show that direct treatment of NF-jB decoy ODN was sufficient to inhibit NF-jB activity and target gene expression in macrophage cells. This could be explained by the fact that CD11b, which is a macrophage surface marker, has been reported to be a cellular surface receptor for oligonucleotides [41] . The ODN used in current study may be taken up by macrophages through a receptor-mediated endocytosis pathway. Recent studies have reported that direct treatment of decoy ODN cannot become translocated into the cells without an appropriate carrier [12] . The contradictory results reported herein may be due to ODN sequence differences, because cell receptormediated ODN uptake is known to be sensitive to the sequence specificity [42] .
Conclusion
Local administration of NF-jB decoy ODN may potentially mitigate wear-particle-and endotoxin-induced pro-inflammatory cytokine expression in macrophages. Thus, the strategic use of NF-jB ODN, delivered locally, could potentially diminish wearparticle-induced periprosthetic osteolysis.
